893 related articles for article (PubMed ID: 16735483)
1. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease.
Meigs JB; Wilson PW; Fox CS; Vasan RS; Nathan DM; Sullivan LM; D'Agostino RB
J Clin Endocrinol Metab; 2006 Aug; 91(8):2906-12. PubMed ID: 16735483
[TBL] [Abstract][Full Text] [Related]
2. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men.
Arnlöv J; Ingelsson E; Sundström J; Lind L
Circulation; 2010 Jan; 121(2):230-6. PubMed ID: 20038741
[TBL] [Abstract][Full Text] [Related]
3. Different obesity phenotypes, and incident cardiovascular disease and mortality events in elderly Iranians: Tehran lipid and glucose study.
Mirbolouk M; Asgari S; Sheikholeslami F; Mirbolouk F; Azizi F; Hadaegh F
Geriatr Gerontol Int; 2015 Apr; 15(4):449-56. PubMed ID: 24750352
[TBL] [Abstract][Full Text] [Related]
4. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
Shand BI; Scott RS; Lewis JG; Elder PA; Frampton CM
Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
[TBL] [Abstract][Full Text] [Related]
5. Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity.
Song SH; Hardisty CA
QJM; 2008 Nov; 101(11):875-9. PubMed ID: 18776208
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes.
Utzschneider KM; Van de Lagemaat A; Faulenbach MV; Goedecke JH; Carr DB; Boyko EJ; Fujimoto WY; Kahn SE
Obesity (Silver Spring); 2010 Sep; 18(9):1781-7. PubMed ID: 20379148
[TBL] [Abstract][Full Text] [Related]
7. Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals.
Voulgari C; Tentolouris N; Dilaveris P; Tousoulis D; Katsilambros N; Stefanadis C
J Am Coll Cardiol; 2011 Sep; 58(13):1343-50. PubMed ID: 21920263
[TBL] [Abstract][Full Text] [Related]
8. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
[TBL] [Abstract][Full Text] [Related]
9. The metabolic syndrome, insulin resistance, and cardiovascular risk in diabetic and nondiabetic patients.
Saely CH; Aczel S; Marte T; Langer P; Hoefle G; Drexel H
J Clin Endocrinol Metab; 2005 Oct; 90(10):5698-703. PubMed ID: 16091486
[TBL] [Abstract][Full Text] [Related]
10. Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk.
Salazar MR; Carbajal HA; Espeche WG; Dulbecco CA; Aizpurúa M; Marillet AG; Echeverría RF; Reaven GM
Diab Vasc Dis Res; 2011 Apr; 8(2):109-16. PubMed ID: 21562062
[TBL] [Abstract][Full Text] [Related]
11. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.
Onat A; Hergenç G; Türkmen S; Yazici M; Sari I; Can G
Metabolism; 2006 Apr; 55(4):445-52. PubMed ID: 16546474
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
Amoah AG; Schuster DP; Gaillard T; Osei K
Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
[TBL] [Abstract][Full Text] [Related]
13. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
Persson M; Hedblad B; Nelson JJ; Berglund G
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
[TBL] [Abstract][Full Text] [Related]
14. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study.
Hadaegh F; Shafiee G; Ghasemi A; Sarbakhsh P; Azizi F
Diabetes Res Clin Pract; 2010 Mar; 87(3):342-7. PubMed ID: 20004035
[TBL] [Abstract][Full Text] [Related]
15. Higher mortality in metabolically obese normal-weight people than in metabolically healthy obese subjects in elderly Koreans.
Choi KM; Cho HJ; Choi HY; Yang SJ; Yoo HJ; Seo JA; Kim SG; Baik SH; Choi DS; Kim NH
Clin Endocrinol (Oxf); 2013 Sep; 79(3):364-70. PubMed ID: 23330616
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome and insulin resistance significantly correlate with body mass index.
Esteghamati A; Khalilzadeh O; Anvari M; Ahadi MS; Abbasi M; Rashidi A
Arch Med Res; 2008 Nov; 39(8):803-8. PubMed ID: 18996295
[TBL] [Abstract][Full Text] [Related]
17. The effect of metformin on the incidence of type 2 diabetes mellitus and cardiovascular disease risk factors in overweight and obese subjects--the Carmos study.
Andreadis EA; Katsanou PM; Georgiopoulos DX; Tsourous GI; Yfanti GK; Gouveri ET; Diamantopoulos EJ
Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):175-80. PubMed ID: 19053032
[TBL] [Abstract][Full Text] [Related]
18. Effect of different obesity phenotypes on cardiovascular events in Tehran Lipid and Glucose Study (TLGS).
Hosseinpanah F; Barzin M; Sheikholeslami F; Azizi F
Am J Cardiol; 2011 Feb; 107(3):412-6. PubMed ID: 21257007
[TBL] [Abstract][Full Text] [Related]
19. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
Meyer C; McGrath BP; Teede HJ
J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
[TBL] [Abstract][Full Text] [Related]
20. Increased cellular and circulating biomarkers of oxidative stress in nascent metabolic syndrome.
Jialal I; Devaraj S; Adams-Huet B; Chen X; Kaur H
J Clin Endocrinol Metab; 2012 Oct; 97(10):E1844-50. PubMed ID: 22872691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
